Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Psychosis Drug Also Shows Promise in Dementia Cases

Nuplazid Nets $94.6 Million In Q3 SalesA drug from Acadia Pharmaceuticals made dementia patients nearly three times less likely to relapse into psychosis.

La Jolla Laser Vision & Eye Center Acquired

Acuity Eye Group has purchased La Jolla Laser Vision & Eye Center for an undisclosed amount.

Vividion Therapeutics Lures Former Pfizer Executive

Vividion Therapeutics – a San Diego upstart that last year raised an $82 million financing round – has announced the hiring of a former Pfizer executive.

Biotechs in San Diego Join Race to Combat Coronavirus

MEDICINE: Investor Interest Swirls around Companies

A crop of life sciences companies are rushing to combat the coronavirus outbreak, triggering big movements in their stocks and millions in grant funding.

Tease photo

Illumina Adds Former FDA Commissioner to Board

Illumina recently made a major addition to its board: Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration.

Gates Foundation Awards $50M to Scripps Research

The Bill & Melinda Gates Foundation has awarded $50 million to a division of Scripps Research to push forward potential therapies for tuberculosis and malaria.

Carlsbad Nonprofit Awarded $450K Chan-Zuckerberg Grant

The Association for Creatine Deficiencies was awarded a $450,000 grant to combat a trio of disorders that can cause intellectual delays.

MeBe to Open Autism and Special Needs Center in Kearny Mesa

San Diego company MeBe on Feb. 15 is slated to open a center catering to young adults and children with autism and special needs.

Histogen to Go Public Via Merger With Conatus

Conatus Pharmaceuticals has agreed to merge with another San Diego biotech, Histogen, it was announced Jan. 28.

Biotech Awarded up to $9M to Develop Coronavirus Vaccine

Inovio Pharmaceuticals was recently awarded up to a $9 million grant to develop a vaccine against a strain of coronavirus that’s spreading in China and spurred screening at U.S. airports.

Illumina Reports 10% Revenue Increase in Q4

Illumina reported revenue of $953 million in fourth quarter revenue, a 10% year-over-year increase that also beat analyst expectations.

ResMed Settles Kickback Allegations, Agrees to Pay $37.5M

ResMed will pay $37.5 million to settle allegations that the company paid kickbacks to suppliers, sleep labs and other health care providers, the Department of Justice recently announced.

Tyra Biosciences Raises $50M to Take On Drug Resistant Cancers

Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has raised a $50 million round.

San Diego Companies Find Deals and Dollars at Health Conference

Two DNA sequencing companies raised more than $140 million combined, Daré Bioscience inked a potential commercialization deal worth up to $310 million, and Human Longevity sold its cancer division for $37 million, and separately, acquired a company.

Tease photo

Neurocrine Gains Option to License Epilepsy Drug; Deal Worth up to $412M

San Diego-based Neurocrine could buy the rights to yet another experimental epilepsy drug, per a recently announced agreement that could be worth up to $412 million.

DNA Sequencing Company Element Biosciences Raises $80.3M Round

Element Biosciences, another San Diego upstart that’s trying to make DNA technology more accessible, recently raised an $80.3 million round.